2026 Ono Golden Ticket Winner

Ono Pharmaceutical Co., Ltd. (Ono) and MBC BioLabs are delighted to announce ASERTI Pharmaceutical as the winner of the 2026 Ono Golden Ticket. The ASERTI Pharmaceutical team was selected from a competitive applicant pool for their potential to generate transformational therapies.

ASERTI will receive sponsored access to an MBC BioLabs laboratory facility and access to our core lab filled with cutting-edge technology to advance their research and development. They will also receive mentoring and guidance from Ono’s renowned team of scientists and pharmaceutical business leaders.

Congratulations to the ASERTI Pharmaceutical team!

ASERTI Pharmaceutical is pioneering a new modality for targeted protein regulation using Selective Endoplasmic Reticulum Translocation Inhibitors (SERTIs). By selectively blocking transport of proteins through the Sec61 channel during synthesis, SERTIs drive degradation before targets ever become functional—reaching therapeutically vital proteins beyond the intracellular reach of PROTACs and molecular glues. ASERTI’s platform pairs deep founder expertise in Sec61 biology and medicinal chemistry with AI-enabled molecular design to rationally engineer protein-specific therapeutics. SERTIs have broad potential across oncology, immunology, neurology, and cardiometabolic disease. To propel its drug pipelines, ASERTI is developing the SERTAIN drug design platform.

Ono Pharmaceutical Co., Ltd. delivers innovative therapies for patients worldwide. Upholding its philosophy of “Dedicated to the Fight against Disease and Pain,” Ono targets areas with unmet medical needs including oncology, immunology & inflammation, and neurology, and fosters partnerships with academic and biotech organizations to accelerate drug discovery. Through its affiliate, Deciphera Pharmaceuticals, Ono is accelerating clinical development and commercial operations in the US and Europe to drive global business expansion and further its commitment to patient care. For more information, please visit the company’s website at https://www.ono-pharma.com/en.

At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems. For more information, visit www.mbcbiolabs.com.